700 Phase II study with topotecan (T) administered as a 21-days continuous infusion to patients with colorectal cancer von Creemers, G.J., Gerrits, C.H.J., Planting, A.S.Th, Schellens, J.H.M., Burg, M.E.L. v.d., de Boer-Dennert, M., Harteveld, M., Hudson, I., Stoter, G., Verweiji, J.

Volltext

Feasibility study of high dose ifosfamide (I) plus cisplatin (C) combined with rh-GCSF every 2 weeks in advanced solid tumors von Planting, A., Goey, S., v.d. Burg, M.E.L., Stoter, G., Verweij, J.

Volltext

Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy von de Wit, R., van der Burg, M. E. L., Gaast, A. v.d., Logmans, A., Stoter, G., Verweij, J.

Volltext

The prognostic significance of epidermal growth factor receptors (EGF-R) - determined immunohistochemically and by Scatchard analysis - in (advanced) ovarian cancer von Rodenburg, C.J., Logmans, S.C.Henzen, van der Burg, M.E.L., Berns, P.M.J.J., v.d. Gaast, A., van Putten, W.L.J., Klijn, J.G.M., Foekens, J.A.

Volltext